Know Labs to Integrate Bitcoin as Core Asset with $12M-$15M Cash Infusion

Know Labs, Inc. has entered into a significant agreement with fintech investor Greg Kidd’s Goldeneye 1995 LLC, involving a transfer of 1,000 Bitcoin. This deal is set to redefine the company's corporate strategy and financial structure. The transaction includes not only the substantial Bitcoin allocation but also a cash infusion ranging from $12 million to $15 million. This financial package is aimed at debt repayment, repurchasing preferred stock, and bolstering working capital, indicating a robust financial restructuring for Know Labs.

Greg Kidd, who is known for his early investments in prominent companies like Twitter, Square, and Coinbase, emphasized the strategic importance of this move. He highlighted that the current market and regulatory conditions are particularly favorable for deploying a Bitcoin treasury strategy. Kidd’s appointment as CEO and Chairman of Know Labs marks a significant leadership transition for the company. His vision is to integrate a pioneering Bitcoin yield strategy into the public markets through Know Labs, positioning Bitcoin as the company’s primary asset.

The transaction has received unanimous approval from Know Labs’ board, with approximately 37% of shareholders already backing the deal. This strong governance support is critical for the anticipated closing later this year. Key personnel changes include Ron Erickson, the company’s founder, transitioning to Vice Chairman and President of a new research division with a salary adjustment, while Peter Conley will step down post-closing. The deal is expected to close in Q3 2025, pending shareholder approval.

This strategic move by Know Labs represents a pioneering example of a health-tech company embracing Bitcoin as a core treasury asset. By leveraging Bitcoin’s value and Kidd’s fintech acumen, Know Labs aims to unlock new avenues for capital growth and investor engagement. The company’s approach to tracking market valuation through mNAV multiples offers a novel framework for assessing the interplay between cryptocurrency assets and traditional equity. Investors and market watchers should closely monitor Know Labs’ performance post-transaction, as it may influence broader trends in corporate Bitcoin adoption and fintech innovation.

In summary, Know Labs’ agreement with Greg Kidd’s Goldeneye 1995 LLC, featuring a substantial Bitcoin allocation and cash infusion, signals a strategic pivot towards integrating cryptocurrency into corporate finance. With strong leadership, shareholder backing, and a clear focus on leveraging Bitcoin’s market potential, Know Labs is poised to navigate a transformative phase that could reshape its financial landscape and inspire similar moves within the industry. This development highlights the growing intersection of fintech expertise and blockchain assets in driving corporate innovation.